Covered recipient · General Payments record
JONATHAN IAN WELTZ
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2021–2024
$1,847.75
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,374.36 | 48 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $148.23 | 2 |
| Kite Pharma, Inc. | $124.46 | 1 |
| GENZYME CORPORATION | $105.09 | 4 |
| Incyte Corporation | $83.70 | 3 |
| Regeneron Healthcare Solutions, Inc. | $83.11 | 4 |
| EISAI INC. | $81.84 | 3 |
| Merck Sharp & Dohme Corporation | $77.95 | 3 |
| Acerta Pharma LLC | $67.23 | 3 |
| Rigel Pharmaceuticals, Inc. | $63.70 | 2 |
| Daiichi Sankyo Inc. | $62.01 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $55.81 | 2 |
| Lilly USA, LLC | $47.53 | 2 |
| Deciphera Pharmaceuticals Inc. | $45.21 | 2 |
| Astellas Pharma US Inc | $39.11 | 2 |
| Genentech USA, Inc. | $31.25 | 1 |
| Adaptive Biotechnologies Corporation | $28.76 | 1 |
| Mirati Therapeutics, Inc. | $28.70 | 1 |
| TerSera Therapeutics LLC | $27.23 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $26.84 | 1 |
| Alexion Pharmaceuticals, Inc. | $22.99 | 1 |
| ARRAY BIOPHARMA INC | $22.31 | 1 |
| BeiGene USA, Inc. | $21.65 | 1 |
| Janssen Biotech, Inc. | $20.21 | 1 |
| Gilead Sciences, Inc. | $20.18 | 1 |
| Celgene Corporation | $20.12 | 1 |
| GlaxoSmithKline, LLC. | $19.14 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (48)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2021 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.